ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Evaluation of Drug Action on IgM Memory B Cell Survival and Growth In Vitro; -Application for Individualized Immunosuppression after Kidney Transplants-

Y. Matsuda,1 K. Takahashi,1 R. Imamura,2 N. Nonomura,2 Y. Yuzawa.1

1Nephrology, Fujita Health University, Toyoake, Aichi, Japan
2Urology, Osaka University, Suita, Osaka, Japan.

Meeting: 2018 American Transplant Congress

Abstract number: D36

Keywords: Antibodies, B cells, Kidney transplantation

Session Information

Session Name: Poster Session D: Immunosuppression Preclinical Studies

Session Type: Poster Session

Date: Tuesday, June 5, 2018

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

(Background)

Recently, the establishment of early diagnosis and treatment methods for antibody-mediated rejection (ABMR) has garnered much attention.

Strong immunosuppression including desensitization is accompanied by severe side effects and is known to be necessary for IgG donor-specific HLA antibody (DSA) depletion after antibody production from serum.

(Method)

IgM memory B cells (mBCs) obtained from 10 healthy donors were cultured with IL-21, CpG-ODN, and PBMC supernatant including cytokine and growth factor produced from activated T cells and inflammatory cells in vitro as basic culture medium.

Additionally, AffiniPure F(ab)2 Fragment Goat Anti-human IgM was added to the basic culture medium to induce IgM mBC class-switching through IgM B cell receptor cross-linking.

At each differentiation stage, drug action of everolimus (EVR), cyclosporine (CYA), tacrolimus (TAC), mycophenolic acid (MPA), and prednisolone (PRD) were analyzed.

Dead cells were stained by 7-AAD, and plasma cells (PCs) were identified as CD20 (low) CD38 (high) CD138 (+) cells by FACS.

(Result)

7-AAD expression on cultured cells was significantly upregulated in MPA (400 ng/mL) and PRD (100 ng/mL) groups (P < 0.05, P < 0.05) compared with that in the control group (Fig1-1). The ratio of PCs/total cells in the EVR (1ng/ml, 5 ng/mL) groups were significantly decreased (P < 0.05, P < 0.01) (Fig1-2). IgG expression was significantly decreased in the EVR (5 ng/mL), CYA (400 ng/mL), and TAC (25 ng/mL) groups (P < 0.05, P < 0.05, P < 0.05) (Fig1-3).

(Conclusion)

MPA and PRD suppressed IgM mBC survival; EVR suppressed both its differentiation into PC and class switching into IgG. CYA and TAC suppressed class switching. Therefore, the appropriate administration of immunosuppressive agents on DSA-specific IgM mBC might prevent the differentiation of DSA specific-IgG mBC, which might cause ABMR development (Fig1-4).

CITATION INFORMATION: Matsuda Y., Takahashi K., Imamura R., Nonomura N., Yuzawa Y. Evaluation of Drug Action on IgM Memory B Cell Survival and Growth In Vitro; -Application for Individualized Immunosuppression after Kidney Transplants- Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Matsuda Y, Takahashi K, Imamura R, Nonomura N, Yuzawa Y. Evaluation of Drug Action on IgM Memory B Cell Survival and Growth In Vitro; -Application for Individualized Immunosuppression after Kidney Transplants- [abstract]. https://atcmeetingabstracts.com/abstract/evaluation-of-drug-action-on-igm-memory-b-cell-survival-and-growth-in-vitro-application-for-individualized-immunosuppression-after-kidney-transplants/. Accessed May 16, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences